Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation
Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, David Barras, Isaac Crespo, Alizée J Grimm, Julia Casado, Raphaël Genolet, Fabrizio Benedetti, Alexandre Wicky, Kalliopi Ioannidou, Wilson Castro, Christopher L. Neal, Amandine Moriot, Stéphanie Renaud-Tissot, Victor Anstett, Noémie Fahr, János L. Tanyi, Monika A. Eiva, Connor A. Jacobson, Kathleen T. Montone, Marie Christine Wulff Westergaard, Inge Marie Svane, Lana E. Kandalaft, Mauro Delorenzi, Peter K. Sorger, Anniina Färkkilä, Olivier Michielin, Vincent Zoete, Santiago J. Carmona, Periklis Foukas, Daniel J. Powell, Sylvie Rusakiewicz, Marie‐Agnès Doucey, Denarda Dangaj Laniti, George Coukos
Topics & Concepts
BlockadeCD28Cancer researchCytotoxic T cellImmunologyBiologyT cellCD8AntigenCTLA-4Cell biologyImmune systemReceptorIn vitroBiochemistryImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersImmune cells in cancer